RAD51 Inhibitor B02

Alternative_Names

BO2
CAS

1290541-46-6
MWt

339.39
Formula

C22H17N3O
Solubility

DMSO: ≥ 37 mg/mL
Clinical_Information

No Development Reported
Pathway

Cell Cycle/DNA Damage
Target

RAD51
Datasheet
SDS
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Identity

HGNC:9817
Gene

RAD51
Long gene name

RAD51 recombinase
Synonyms gene
- RAD51A
- RECA
Synonyms gene name
- RAD51 (S. cerevisiae) homolog (E coli RecA homolog)
- RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)
- RAD51 homolog (S. cerevisiae)
Synonyms
- HsRad51
- HsT16930
- BRCC5
- FANCR
Synonyms name
- BRCA1/BRCA2-containing complex, subunit 5
GenBank acession
- D13804
Locus

15q15.1
Discovery year

1993-05-26
Entrez gene record

5888
Pubmed identfication
- 8358431
- 8479919
- 26253028
RefSeq identity
- NM_002875
- NM_133487
Classification
- FA complementation groups
VEGA ID

OTTHUMG00000130067
Locus Specific Databases
- Fanconi Anaemia Mutation Database
- LRG_313